Subependymal giant cell astrocytomas (SEGAs) are low-grade intraventricular glial tumors that develop in 10-15% of patients with tuberous sclerosis complex; they often cause hydrocephalus and are potentially accessible to a surgical treatment. Our aim is to evaluate morbidity and results after surgery in symptomatic and asymptomatic patients. We present a retrospective series of 18 pediatric patients operated on for SEGA between 2006 and 2016 at our institution. We reviewed surgical indications, preoperative clinical and radiologic data, surgical management, and clinical and radiological follow-up. Mean age at surgery was 10.7 years. The surgical decision was based on clinical signs of raised intracranial pressure due to hydrocephalus in 8 and on radiological findings without any clinical signs in the other 10 patients (increased in SEGA volume with or without ventricular enlargement). Surgical treatment consisted in a frontal trans-ventricular microsurgical approach in 17 patients and an endoscopic approach in 1. External ventricular drainage was placed in all the patients but 1. Ventriculoperitoneal shunting (VPS) became necessary in 6 patients, all of them presenting with a preoperative active hydrocephalus. Morbidity appeared very low with meningitis occurring in 1 patient. Resection was complete in 15 children with no recurrence during a mean follow-up of 5.25 years and incomplete in 3 requiring a second surgery. Surgery of SEGA represents a very effective treatment with low morbidity and no mortality in the present series. In patients operated before the onset of clinical signs of hydrocephalus, internal VPS could be avoided whereas in others, an additional shunt surgery became necessary. This gives arguments in favor of a regular MRI surveillance in tuberous sclerosis complex patients with SEGA in order to best propose resective surgery once a growth of tumor and/or ventricular size have been confirmed but before raised intracranial pressure occurs.
机构:
Chung Shan Med Univ, Sch Med, 110 Sect 1,Jianguo North Rd, Taichung 402, Taiwan
Chung Shan Med Univ Hosp, Dept Pediat, 110 Sect 1,Jianguo North Rd, Taichung 402, TaiwanChung Shan Med Univ, Sch Med, 110 Sect 1,Jianguo North Rd, Taichung 402, Taiwan
Tsai, Jeng-Dau
Wei, Chang-Ching
论文数: 0引用数: 0
h-index: 0
机构:
China Med Univ Hosp, Childrens Hosp, Taichung, Taiwan
China Med Univ, Sch Med, Taichung, TaiwanChung Shan Med Univ, Sch Med, 110 Sect 1,Jianguo North Rd, Taichung 402, Taiwan
Wei, Chang-Ching
Tsao, Teng-Fu
论文数: 0引用数: 0
h-index: 0
机构:
Chung Shan Med Univ, Sch Med, 110 Sect 1,Jianguo North Rd, Taichung 402, Taiwan
Chung Shan Med Univ Hosp, Dept Med Imaging, Taichung 40201, TaiwanChung Shan Med Univ, Sch Med, 110 Sect 1,Jianguo North Rd, Taichung 402, Taiwan
Tsao, Teng-Fu
Hsiao, Yu-Ping
论文数: 0引用数: 0
h-index: 0
机构:
Chung Shan Med Univ, Sch Med, 110 Sect 1,Jianguo North Rd, Taichung 402, Taiwan
Chung Shan Med Univ Hosp, Dept Dermatol, Taichung 40201, TaiwanChung Shan Med Univ, Sch Med, 110 Sect 1,Jianguo North Rd, Taichung 402, Taiwan
Hsiao, Yu-Ping
Tsai, Henry J.
论文数: 0引用数: 0
h-index: 0
机构:
Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, TaiwanChung Shan Med Univ, Sch Med, 110 Sect 1,Jianguo North Rd, Taichung 402, Taiwan
Tsai, Henry J.
Yang, Sheng-Hui
论文数: 0引用数: 0
h-index: 0
机构:
Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, TaiwanChung Shan Med Univ, Sch Med, 110 Sect 1,Jianguo North Rd, Taichung 402, Taiwan
Yang, Sheng-Hui
Tsai, Min-Ling
论文数: 0引用数: 0
h-index: 0
机构:
Chung Shan Med Univ, Sch Med, 110 Sect 1,Jianguo North Rd, Taichung 402, Taiwan
Chung Shan Med Univ Hosp, Dept Pharm, Taichung 40201, TaiwanChung Shan Med Univ, Sch Med, 110 Sect 1,Jianguo North Rd, Taichung 402, Taiwan
Tsai, Min-Ling
Sheu, Ji-Nan
论文数: 0引用数: 0
h-index: 0
机构:
Chung Shan Med Univ, Sch Med, 110 Sect 1,Jianguo North Rd, Taichung 402, Taiwan
Chung Shan Med Univ Hosp, Dept Pediat, 110 Sect 1,Jianguo North Rd, Taichung 402, TaiwanChung Shan Med Univ, Sch Med, 110 Sect 1,Jianguo North Rd, Taichung 402, Taiwan